New cancer clinical trial: An Investigational Immunotherapy Study of BMS-986258 Alone and in Combination With Nivolumab in Participants With Solid Cancers That Are Advanced or Have Spread

Published on: February 26, 2018 at 12:00PM
Condition:   Advanced Cancer
Interventions:   Biological: BMS-986258;   Biological: Nivolumab
Sponsor:   Bristol-Myers Squibb
Not yet recruiting
http://ift.tt/2EYdvNS